mRNA company Moderna raises $500M series G

Moderna Therapeutics Inc. (Cambridge, Mass.) raised $500 million in an untranched series G round on Feb. 1.

New investors included an Abu Dhabi Investment Authority subsidiary, BB Biotech AG (SIX:BION; Xetra:BBZA), Julius Baer, EDBI and Sequoia Capital China. Existing investors Fidelity, Pictet, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments also participated...